SCHEMBL1699236

SCHEMBL1699236

CCn1c(S(C)(=O)=O)nc2cccnc21

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2C19 P33261 1/20 0.47
POLB P06746 3/20 0.46
HPGD P15428 3/20 0.45
MAPT P10636 1/20 0.45
KDM4E B2RXH2 2/20 0.44
LMNA P02545 2/20 0.43
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
MAPK1 P28482 1/20 0.43
ALDH1A1 P00352 1/20 0.40
ENPP2 Q13822 1/20 0.40
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL569209 0.83 NPSR1 (0.50) CYP1A2CYP2C19POLBHPGDMAPT
SCHEMBL569436 0.83 CYP1A2 (0.43) S1PR1CYP1A2CYP2C19POLBMAPT
SCHEMBL19771403 0.81 POLB (0.53) CYP1A2CYP2C19POLBMAPTLMNA
SCHEMBL569392 0.80 MAPT (0.43) CYP1A2CYP2C19POLBMAPTKDM4E
SCHEMBL31163679 0.78 S1PR1 (0.48) S1PR1
SCHEMBL17966923 0.76 ENPP2 (0.61) CYP1A2CYP2C19POLBMAPTLMNA
SCHEMBL12593484 0.74 MEN1 (0.51) S1PR1POLBMAPTKDM4ELMNA
SCHEMBL2247954 0.74 S1PR1 (0.49) S1PR1CYP1A2CYP2C19KDM4ELMNA
SCHEMBL1979492 0.74 CYP1A2 (0.57) S1PR1CYP1A2CYP2C19POLBMAPT
SCHEMBL18885590 0.74 KDM4E (0.44) S1PR1POLBHPGDMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012176934-A1 CRYSTAL OF FUSED HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-12-27 WO disclosed
WO-2011163355-A1 FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-12-29 WO disclosed